D-Mannose contraceptives
AssigneeBioTech Pharmacal, Inc.
InventorDale L. Benedict
Life of this patent
Estimating the term…
Abstract
The present invention concerns the use of D-Mannose to prevent or inhibit uniting of sperm and egg in the conception process. The administration of D-Mannose to a female such that the environment of an egg has sufficient D-Mannose to inhibit interaction of sperm and the egg and prevent or inhibit conception. D-Mannose dosages may be complimentary to other methods of birth control to enhance their effectiveness.
Claims12
A method for inhibiting conception comprising, administering D-Mannose to a female in an amount effective to inhibit interaction between a sperm and an egg of said female.
D-Mannose in an amount effective to inhibit interaction between a sperm and an egg for use as a contraceptive when administered to a woman.
Capsules containing D-Mannose in an amount effective to inhibit interaction between a sperm and an egg for use as a contraceptive when administered to a woman.
A method of inhibiting conception comprising administering D-Mannose to a female in an amount effective to inhibit interaction between a sperm and a egg of said female wherein the step of administering said D-Mannose comprises vaginally delivering said D-Mannose to said female.
A method for inhibiting conception comprising administering D-Mannose to a female in an amount effective to inhibit interaction between a sperm and an egg of said female wherein said D-Mannose is administered in the form of a capsule or tablet, said D-Mannose is administered within one day prior to or one day after sexual intercourse and wherein the administration is by means of the female ingesting about three capsules, each capsule containing about 420 milligrams of D-Mannose about every two hours beginning about a day before said intercourse, ingestion being reduced to two or three of such capsules about one hour before intercourse and about the same dosage about one hour thereafter.
Dependencies are inferred from the claim text.